Enovis Corporation ROE 2010-2024 | ENOV
Current and historical return on equity (ROE) values for Enovis Corporation (ENOV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Enovis Corporation ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-09-30 |
$-0.12B |
$3.33B |
-3.59% |
| 2024-06-30 |
$-0.09B |
$3.29B |
-2.70% |
| 2024-03-31 |
$-0.08B |
$3.31B |
-2.41% |
| 2023-12-31 |
$-0.03B |
$3.42B |
-0.96% |
| 2023-09-30 |
$-0.08B |
$3.44B |
-2.18% |
| 2023-06-30 |
$-0.14B |
$3.45B |
-4.04% |
| 2023-03-31 |
$-0.05B |
$3.45B |
-1.51% |
| 2022-12-31 |
$-0.01B |
$3.45B |
-0.37% |
| 2022-09-30 |
$0.02B |
$3.41B |
0.57% |
| 2022-06-30 |
$0.12B |
$3.49B |
2.66% |
| 2022-03-31 |
$0.07B |
$4.64B |
1.49% |
| 2021-12-31 |
$0.07B |
$4.66B |
1.61% |
| 2021-09-30 |
$0.11B |
$4.63B |
2.54% |
| 2021-06-30 |
$0.09B |
$4.35B |
2.40% |
| 2021-03-31 |
$0.06B |
$4.29B |
1.55% |
| 2020-12-31 |
$0.04B |
$3.59B |
1.22% |
| 2020-09-30 |
$-0.01B |
$3.46B |
-0.23% |
| 2020-06-30 |
$-0.01B |
$3.40B |
-0.33% |
| 2020-03-31 |
$-0.47B |
$3.34B |
-14.28% |
| 2019-12-31 |
$-0.53B |
$3.49B |
-15.51% |
| 2019-09-30 |
$-0.47B |
$3.13B |
-13.67% |
| 2019-06-30 |
$-0.44B |
$3.26B |
-12.73% |
| 2019-03-31 |
$0.06B |
$3.74B |
1.77% |
| 2018-12-31 |
$0.14B |
$3.48B |
3.91% |
| 2018-09-30 |
$0.11B |
$3.48B |
2.93% |
| 2018-06-30 |
$0.12B |
$3.54B |
3.34% |
| 2018-03-31 |
$0.14B |
$3.84B |
3.79% |
| 2017-12-31 |
$0.15B |
$3.73B |
4.37% |
| 2017-09-30 |
$0.18B |
$3.51B |
5.34% |
| 2017-06-30 |
$0.16B |
$3.37B |
4.92% |
| 2017-03-31 |
$0.15B |
$3.21B |
4.59% |
| 2016-12-31 |
$0.13B |
$3.09B |
4.08% |
| 2016-09-30 |
$0.14B |
$3.17B |
4.21% |
| 2016-06-30 |
$0.13B |
$3.16B |
3.86% |
| 2016-03-31 |
$0.14B |
$3.24B |
4.17% |
| 2015-12-31 |
$0.17B |
$3.26B |
5.05% |
| 2015-09-30 |
$0.20B |
$3.30B |
6.09% |
| 2015-06-30 |
$0.26B |
$3.43B |
7.61% |
| 2015-03-31 |
$0.40B |
$3.25B |
11.52% |
| 2014-12-31 |
$0.37B |
$3.35B |
10.62% |
| 2014-09-30 |
$0.33B |
$3.54B |
9.76% |
| 2014-06-30 |
$0.30B |
$3.65B |
9.78% |
| 2014-03-31 |
$0.16B |
$3.40B |
5.87% |
| 2013-12-31 |
$0.16B |
$2.74B |
6.46% |
| 2013-09-30 |
$0.14B |
$2.57B |
6.00% |
| 2013-06-30 |
$0.09B |
$2.40B |
4.18% |
| 2013-03-31 |
$0.05B |
$2.06B |
2.16% |
| 2012-12-31 |
$-0.08B |
$2.16B |
-3.83% |
| 2012-09-30 |
$-0.11B |
$2.18B |
-6.81% |
| 2012-06-30 |
$-0.11B |
$2.10B |
-9.58% |
| 2012-03-31 |
$-0.11B |
$2.22B |
-15.27% |
| 2011-12-31 |
$0.01B |
$0.19B |
2.16% |
| 2011-09-30 |
$0.03B |
$0.25B |
12.59% |
| 2011-06-30 |
$0.03B |
$0.25B |
13.70% |
| 2011-03-31 |
$0.02B |
$0.24B |
11.10% |
| 2010-12-31 |
$0.02B |
$0.22B |
8.29% |
| 2010-09-30 |
$0.02B |
$0.23B |
7.31% |
| 2010-06-30 |
$0.02B |
$0.19B |
7.58% |
| 2010-03-31 |
$0.02B |
$0.19B |
8.61% |
| 2009-12-31 |
$0.02B |
$0.22B |
12.53% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$2.428B |
$1.707B |
|
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
